Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China

Nav

General Info

Geography

China (CHN)

Guangxi

Time period covered

01/2010 - 12/2012

Data type

Scientific literature

Keywords

Diarrheal diseases, Rotavirus

Citation

Authors

Li RC, Huang T, Li Y, Luo D, Tao J, Fu B, Si G, Nong Y, Mo Z, Liao X, Luan I, Tang H, Rathi N, Karkada N, Han HH

Journal

Hum Vaccin Immunother

Volume

Issue

Pages

8-Nov

Publication year

2014

Suggested citation

Li RC, Huang T, Li Y, Luo D, Tao J, Fu B, Si G, Nong Y, Mo Z, Liao X, Luan I, Tang H, Rathi N, Karkada N, Han HH. Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China. Hum Vaccin Immunother. 2014; 10(1): 8-Nov.

GHDx Entry last modified on: Sep 3, 2019

Header sites

Search form

Main menu

Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China

Nav